Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Canine IgM μ Chain Specific Monoclonal Antibody-[Biotin]

Product Overview

BioVenic mouse monoclonal antibody is specific for canine IgM μ chain. It can be applied to FCM, IF, IP, IHC, ELISA and WB assays of canine IgM μ chain.

Specifications

Application FCM; IF; IP; IHC; ELISA; WB

Clonality Monoclonal

Classification Labeled Antibody

Clone L14N11

Host Mouse

Target Species Canine

Species Reactivity Canine

Specificity Canine IgM

Purity > 90%

Concentration 1 mg/mL

Conjugation Biotin

Preservative and Stabilizer Sodium Azide

Buffer 0.01M Phosphate Buffered Saline, 0.5% Bovine Serum Albumin and 50% Glycerol

Physical State Liquid

Target Information

Canine IgM μ chain is a crucial component of the immunoglobulin M (IgM) in dogs, which is the first antibody isotype produced in an immune response to antigens. IgM is a pentameric structure, with the μ chain being the heavy chain found in all five Y-shaped monomers. This chain plays a vital role in the initial defense against pathogens, as it can activate the complement system effectively and is particularly efficient at binding to antigens on the surface of pathogens.

Target Canine IgM μ Chain

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid exposure to light. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Sioutas, Georgios, et al. "Seroprevalence of IgG and IgM Antibodies against Toxoplasma gondii in Dogs in Greece." Veterinary Sciences 11.8 (2024): 339.